Presentation TCT 2012 Multivessel Disease 2: Use of Physiologic Lesion Assessment and IVUS to Improve DES Results Presenter: Seung-Jung Park October 22, 2012
Presentation TCT 2012 The Art and Science of Risk Stratification in Aortic Stenosis: Updates on Risk Scores, Futility, and Other Imponderables Presenter: Michael Mack October 22, 2012
Presentation TCT 2012 My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery) Presenter: Rudiger Lange October 22, 2012
Presentation TCT 2012 New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat” Presenter: Jeffrey Popma October 22, 2012
Presentation TCT 2012 The Epidemiology of Valvular Aortic Stenosis in the 21st Century Presenter: Vuyisile Nkomo October 22, 2012
Presentation TCT 2012 Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro! Presenter: Gary Ansel October 22, 2012
Presentation TCT 2012 Updates from the Worldwide Valve-in-Valve TAVR Registry Presenter: Danny Dvir October 22, 2012
Presentation TCT 2012 Appropriate Use of Balloon Aortic Valvuloplasty in Aortic Stenosis Patients Presenter: Helene Eltchaninoff October 22, 2012
Presentation TCT 2012 Update from the Randomized SURTAVI Trial Presenter: Patrick Serruys October 22, 2012
Presentation TCT 2012 Mechanisms of Stem Cell Effects: Insights from MRI in the SCAMI Trial Presenter: Jochen W?hrle October 22, 2012